These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2664267)

  • 1. [Thromboxane synthetase inhibitor and prostacyclin analogue].
    Nakagawa M; Toyoda T
    Nihon Rinsho; 1989 Apr; 47(4):929-34. PubMed ID: 2664267
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
    Vane JR
    J Endocrinol; 1982 Nov; 95(2):3P-43P. PubMed ID: 6816886
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
    Teraoka S; Takahashi K; Toma H; Sanaka T; Yamaguchi Y; Tanabe K; Sato H; Kawaguchi H; Oba S; Nakajima I
    Transplant Proc; 1987 Oct; 19(5):3664-8. PubMed ID: 3313883
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    Moncada S; Vane JR
    Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
    [No Abstract]   [Full Text] [Related]  

  • 5. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M
    Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitors of prostaglandin, prostacyclin, and thromboxane synthesis.
    Vane JR
    Adv Prostaglandin Thromboxane Res; 1978; 4():27-44. PubMed ID: 417572
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of prostacyclin in thromboresistance].
    Kume S; Higashihara M; Tanabe A; Takahata K
    Kokyu To Junkan; 1985 Jul; 33(7):877-81. PubMed ID: 2997895
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostacyclin: a prostaglandin with therapeutic potential.
    Vane JR
    Arch Farmacol Toxicol; 1982 Aug; 8(2):51-76. PubMed ID: 6818907
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575).
    Honn KV; Meyer J; Neagos G; Henderson T; Westley C; Ratanatharathorn V
    Prog Clin Biol Res; 1982; 89():295-331. PubMed ID: 7051034
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
    Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
    Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of vascular thrombosis by products of arachidonic acid metabolism.
    Wu KK; Hall ER; Papp A
    Clin Physiol Biochem; 1984; 2(2-3):84-90. PubMed ID: 6435930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the thromboxane synthetase inhibitor dazoxiben and the prostacyclin mimetic iloprost in an animal model of acute ischaemia and reperfusion.
    Thiemermann C; Schrör K
    Biomed Biochim Acta; 1984; 43(8-9):S151-4. PubMed ID: 6083783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin, from discovery to clinical application.
    Moncada S
    J Pharmacol; 1985; 16 Suppl 1():71-88. PubMed ID: 3897717
    [No Abstract]   [Full Text] [Related]  

  • 15. Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry.
    Backon J
    Med Hypotheses; 1986 Jul; 20(3):271-8. PubMed ID: 3528776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
    Moore JN; Hardee MM; Hardee GE
    Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin in physiology and pathophysiology.
    Vane JR; Bunting S; Moncada S
    Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207
    [No Abstract]   [Full Text] [Related]  

  • 18. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
    Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins and hemostasis: an overview.
    Stuart MJ
    Adv Pediatr; 1983; 30():321-64. PubMed ID: 6231843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.